SETDB2 induces abnormal SHP-1 splicing and promotes immunosuppression in hepatocellular carcinoma
7 April 2026 at 08:00
Oncogene, Published online: 07 April 2026; doi:10.1038/s41388-026-03759-z
SETDB2 induces abnormal SHP-1 splicing and promotes immunosuppression in hepatocellular carcinoma